3177,"designation":{"id":16,"title":"MD"}}],"phone_number":null,"profile_picture":null,"has_financial_relation":true},"conf_role":"session_chair","is_published":false}],"zipcode":"","end_date":"2026-04-11T07:00:00+00:00","isActive":true,"latitude":30.3297566,"location":"","longitude":-81.6591529,"categories":[{"id":65,"category":{"id":10,"image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/0c27eeee-dcee-481e-96fe-4da159b34800","title":"Heme/Onco","description":""}}],"created_at":"2026-01-30T20:07:35.292081+00:00","flyer_link":null,"image_name":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/439b8de0-64bf-439f-b8ec-ae4444593d00/thumbnail","meta_title":"","start_date":"2026-04-11T07:00:00+00:00","updated_at":null,"description":"

The 2026 Clinical Advances & Treatment Challenges in Solid and Hematologic Malignancies, Jacksonville Conference aims to enhance participants’ knowledge and competence in applying practice-changing clinical data and expert recommendations to optimize outcomes for patients with hematologic malignancies. Through scientific debates, panel discussions, and in-depth analysis, the conference will address key controversies and advances in the field, with a focus on integrating innovative therapies into clinical practice. Designed for a multidisciplinary audience of physicians, advanced practice providers, pharmacists, nurses, and other healthcare professionals, the conference emphasizes evidence-based approaches and a patient-centered care model. Participants will gain actionable insights to improve clinical outcomes and stay informed on the latest developments in hematologic malignancies.

","is_cfp_conf":null,"is_published":true,"accreditations":null,"additional_tax":null,"exhibitor_link":"https://www.sponsorships.binaytara.org/JACKHEMEONC","homepage_image":"https://imagedelivery.net/446RhcKSmHi3fzbXKA91IQ/439b8de0-64bf-439f-b8ec-ae4444593d00/thumbnail","additional_info":"","target_audience":"

Medical oncologists and hematologists
Medical oncology and hematology fellows
Oncology nurses
Nurse practitioners
Physician assistants
Pharmacists

","meta_description":"","calculated_credit":null,"learning_objectives":"

Evaluate recent, practice-changing clinical trial data and guideline updates in solid and hematologic malignancies to inform evidence-based treatment decisions.
Apply emerging therapeutic strategies, including novel targeted agents, immunotherapies, and cellular therapies, to optimize individualized patient care across diverse oncology settings.
Identify and address key clinical challenges and controversies in the management of solid and hematologic cancers, including treatment sequencing, toxicity management, and resistance.
Integrate multidisciplinary, patient-centered approaches into oncology practice to improve clinical outcomes, quality of care, and shared decision-making.

","organizing_committee":"

Course Director:

Binay Shah, MD, MHA - Binaytara

Conference Co-Chairs:

Julio Chavez, MD - Mayo Clinic

Pooja Advani, MBBS, MD - Mayo Clinic

","price_additional_info":null,"accreditation_additonal_info":null},"programData":[],"globaldata":{"id":17,"title":"Global","description":"This is global page ","createdAt":"2024-07-23T00:38:43.957Z","updatedAt":"2026-02-21T2

Conferences

Organizing Committee:

Target Audience:

Learning Objectives: